Fig. 2From: The Carpentier-Edwards Perimount Magna mitral valve bioprosthesis: intermediate-term efficacy and durabilityKaplan-Meier non-parametric estimate of all-cause mortality based on the observed survival in patients with the Carpentier-Edwards Magna valve in the mitral position with censoring (N = 70, with n = 16 deaths, 54 censored). X-axis represents time after valve implant, in months. aNumber at risk for each 10 month interval beginning with n of 70Back to article page